Patents Assigned to ONKOSXCEL THERAPEUTICS, LLC
  • Patent number: 11564986
    Abstract: The present invention discloses a method of treating, preventing or ameliorating tumor growth by administering a therapeutic agent that selectively inhibits dipeptidyl peptidase including fibroblast activation protein and dipeptidyl peptidase 8/9 in combination with an immune checkpoint inhibitor. The method specifically discloses use of Talabostat in combination with an immune checkpoint inhibitor, its pharmaceutical composition and process of preparing such composition.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: January 31, 2023
    Assignee: ONKOSXCEL THERAPEUTICS, LLC
    Inventors: Luca Rastelli, Aparna Katoch Sapra, Vimal Mehta